| Filed On | Filing |
|---|---|
| 16 Nov 2026 |
Form 4: Lalor Angela S, Director
Bought 874 shares ($24.5K) · Bought 880 shares ($24.9K) |
| 16 Nov 2026 | SCHEDULE 13G/A |
| 12 Nov 2026 |
Form 4: Wienbar Sharon L, Director
Bought 874 shares ($24.8K) · Bought 900 shares ($25K) |
| 12 Nov 2026 |
Form 4: Lalor Angela S, Director
Bought 887 shares ($25.1K) · Bought 870 shares ($25.1K) |
| 10 Nov 2026 |
Form 4: Wienbar Sharon L, Director
Bought 907 shares ($25K) · Bought 924 shares ($24.9K) |
| 05 Nov 2026 | 10-Q |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
Dallas, TX, November 5, 2026 (GLOBE NEWSWIRE)—Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the third quarter ended October... |
| 01 Oct 2026 |
Form 4: Ortiz Christine, Director
Received 958 shares as a grant or award |
| 08 Sep 2026 |
Form 4: Engert Oliver, Chief Administrative Officer
Bought 2,660 shares ($50K) |
| 04 Sep 2026 |
Form 4: Engert Oliver, Chief Administrative Officer
Bought 2,458 shares ($49.9K) · Bought 5,140 shares ($100K) |
| 04 Sep 2026 |
Form 4: McDonald Damien, Director
Bought 13,035 shares ($250K) |
| 01 Sep 2026 |
8-K: Regulation FD Disclosure
Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics |
| 14 Aug 2026 | SCHEDULE 13G |
| 06 Aug 2026 | 10-Q |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition
Dallas, TX, August 6, 2026 (GLOBE NEWSWIRE)—Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the second quarter ended July 3, ... |
| 28 Jul 2026 | SCHEDULE 13G/A |
| 08 Jul 2026 | SCHEDULE 13G/A |
| 01 Jul 2026 |
Form 4: Ortiz Christine, Director
Received 846 shares as a grant or award |
| 26 Jun 2026 | 11-K |
| 16 Jun 2026 |
Form 4: Engert Oliver, Chief Administrative Officer
Bought 1,000 shares ($20.9K) |
Loading...